Researcher
Iris Dirven
- Keywords:Medicine
- Disciplines:Other basic sciences not elsewhere classified
Affiliations
- Laboratory for Medical and Molecular Oncology (Research group)
Member
From1 Nov 2022 → Today - Medical Oncology (Department)
Member
From1 Oct 2022 → Today - Faculty of Medicine and Pharmacy (Faculty)
Member
From2 Sep 2022 → Today - Faculty of Medicine and Pharmacy (Faculty)
Member
From1 Oct 2020 → Today - Clinical sciences (Department)
Member
From1 Oct 2022 → Today - Clinical sciences (Department)
Member
From1 Oct 2022 → 20 Oct 2022 - Internal medicine (Department)
Member
From1 Oct 2021 → 30 Sep 2022 - Internal medicine (Department)
Member
From1 Sep 2020 → 30 Sep 2020
Publications
1 - 8 of 8
- Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma(2024)
Authors: Jens Tijtgat, Xenia Geeraerts, Anais Boisson, Latoya Stevens, Manon Vounckx, Iris Dirven, Julia Katharina Schwarze, Steven Raeymaeckers, Ramses G Forsyth, Ivan Van Riet, et al.
- Successful Treatment with Dabrafenib/Trametinib of a Malignantly Transformed and Metastasized BRAF V600E Mutant Pleiomorphic Xanthoastrocytoma(2024)
Authors: Elle Bo Vermeulen, An-Sofie Vander Mijnsbrugge, Stefanie Brock, Freya Vaeyens, Iris Dirven, Abdulhamid Ciçek, William Marcelis, Samuel Klein, Michaël Bruneau, Bart Neyns, et al.
Pages: 10-16 - 1136P Regorafenib combined with BRAF-/MEK-inhibitors for the treatment of refractory melanoma brain metastases(2023)
Authors: Iris Dirven, An-Sofie Vander Mijnsbrugge, Jens Tijtgat, Manon Vounckx, Bart Neyns
Pages: 681-681 - Development and Validation of a Predictive Model for Metastatic Melanoma Patients Treated with Pembrolizumab Based on Automated Analysis of Whole-Body [18F]FDG PET/CT Imaging and Clinical Features(2023)
Authors: Ine Dirks, Marleen Keyaerts, Iris Dirven, Bart Neyns, Jef Vandemeulebroucke
- Auto-immune hemolytic anemia and hemophagocytic lymphohistiocytosis as immune-related adverse event in patients with metastatic melanoma and concurrent chronic lymphocytic leukemia(2023)
Authors: Iris Dirven, An-Sofie Vander Mijnsbrugge, Sacha Mignon, Jens Tijtgat, Nicolas Kint, Bart Neyns
Pages: 338-344 - Trajectory of neutrophilic responses in a mouse model of pollutant-aggravated allergic asthma(2023)
Authors: Joyceline De Volder, Annelies Bontinck, Katrien De Grove, Iris Dirven, Valerie Haelterman, Guy Joos, Guy G. Brusselle, Tania Maes
- Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series(2023)
Authors: Jens Tijtgat, Evan Maarten Calliauw, Iris Dirven, Manon Vounckx, Randa Kamel, A Vanbinst, Hendrik Everaert, Laura Seynaeve, Dirk Van Den Berge, Johnny Duerinck, et al.
- Lymphadenopathy after COVID-19 vaccination in patients with endocrine cancer(2022)
Authors: Iris Dirven, Bert Bravenboer, Steven Raeymaeckers, Corina Andreescu
Pages: 1-5